Revance is a biotechnology company focused on peptide-enhanced neuromodulator products for aesthetic and therapeutic use. The organization employs just over 550 people and recent talent records show roughly 90 new hires balanced by a similar number of departures, keeping overall headcount steady. This stable workforce supports the company’s continued clinical development and commercial activities.
Revance’s largest group is Healthcare—including clinical, medical, and regulatory specialists—with about 107 employees, or roughly one-fifth of total staff. Sales & Support follows closely at 101 employees, underpinning commercial outreach as products reach the market. Engineering roles number 81 and reflect the technical work required for drug formulation and delivery platforms. Smaller but important functions such as Marketing & Product, Business Management, Finance & Administration, and Operations each represent between 7 % and 8 % of headcount, while Consulting, Quality, and other specialized teams round out the roster.
Employee data indicates a distributed footprint anchored in several U.S. life-science hubs. San Francisco hosts the largest single cohort at about 91 employees, aligning with the region’s established biotech ecosystem. Nashville accounts for roughly 59 team members and provides central access to healthcare talent. Additional concentrations are found in Los Angeles, New York, Dallas, and several smaller clusters, while a substantial number of employees work remotely or at satellite sites grouped under “Other,” giving Revance the flexibility to recruit talent nationwide.